HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charlotte Hauser Selected Research

APG350

1/2018The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Charlotte Hauser Research Topics

Disease

13Neoplasms (Cancer)
01/2022 - 06/2002
5Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2014
5Neoplasm Metastasis (Metastasis)
05/2019 - 04/2015
4Adenocarcinoma
01/2023 - 01/2018
4Breast Neoplasms (Breast Cancer)
04/2015 - 06/2002
1Circulating Neoplastic Cells
12/2021
1Esophageal Neoplasms (Esophageal Cancer)
10/2019
1Melanoma (Melanoma, Malignant)
01/2019
1Pathologic Constriction (Stenosis)
01/2018
1Anastomotic Leak
01/2018
1Sepsis (Septicemia)
01/2018
1Cholangiocarcinoma
01/2016
1Appendicitis
01/2015
1Hypothermia
01/2013
1Inflammation (Inflammations)
07/2011
1Endometrial Neoplasms (Endometrial Cancer)
12/2006

Drug/Important Bio-Agent (IBA)

2ChemokinesIBA
09/2019 - 04/2015
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2019 - 01/2018
2Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2014
2Death Domain ReceptorsIBA
07/2018 - 01/2014
2Dopamine (Intropin)FDA LinkGeneric
01/2013 - 07/2011
2Adrenergic Receptors (Adrenergic Receptor)IBA
01/2013 - 07/2011
2SteroidsIBA
10/2004 - 06/2002
2ProgesteroneFDA LinkGeneric
10/2004 - 06/2002
1Liposomes (Liposome)IBA
01/2022
1Immunoglobulin Fab FragmentsIBA
01/2022
1IronIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
12/2021
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
05/2019
1argatroban (MPQA)FDA Link
01/2019
1Hyaluronic Acid (Hyaluronan)IBA
01/2019
1NestinIBA
08/2018
1Cadherins (E-Cadherin)IBA
08/2018
1navitoclaxIBA
01/2018
1APG350IBA
01/2018
1LigandsIBA
01/2018
1Potassium Channels (Potassium Channel)IBA
10/2017
1Ion Channels (Ion Channel)IBA
10/2017
1Small Interfering RNA (siRNA)IBA
05/2017
1Blocking AntibodiesIBA
05/2017
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2016
1MTOR InhibitorsIBA
01/2016
1tocilizumab (atlizumab)FDA Link
09/2015
1Interleukin-6 (Interleukin 6)IBA
09/2015
1GemcitabineFDA Link
09/2015
1Ribosomal DNA (rDNA)IBA
01/2015
1Peptides (Polypeptides)IBA
01/2015
1CytokinesIBA
01/2015
1Interleukin-8 (Interleukin 8)IBA
01/2015
1DefensinsIBA
01/2015
1MicroRNAs (MicroRNA)IBA
01/2014
1CatecholaminesIBA
01/2013
1Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2013
1DobutamineFDA LinkGeneric
01/2013
1Steroid Receptors (Steroid Receptor)IBA
12/2006
1CholesterolIBA
10/2004
1Estradiol (Delestrogen)FDA LinkGeneric
06/2002
1LipidsIBA
06/2002
1CyclodextrinsIBA
06/2002

Therapy/Procedure

7Therapeutics
01/2023 - 04/2015
2Esophagectomy
10/2019 - 01/2018
1Heterologous Transplantation (Xenotransplantation)
01/2018
1Length of Stay
01/2018
1Palliative Care (Palliative Therapy)
01/2018